RxDoctor Payments Data

Christopher Rucker, MD

Internal Medicine · Norton, OHNPI 1114115581

Payments from drug & device makers

$10,136in general payments, 2019–2025

Across 705 payments — averaging $14.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • GSK$1K
  • AstraZeneca$895
  • Lilly USA, LLC$893
  • Pfizer$735
  • plus $4K from 37 others

What the payments were for

  • Food & beverage$10,123100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,136 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$132,383
Medicare patients
255
Services billed
1,965

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban140$177,342
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$57,555
OzempicSemaglutide23$48,686
FarxigaDapagliflozin Propanediol50$43,013
JardianceEmpagliflozin35$38,581
Tresiba Flextouch U-200Insulin Degludec17$36,707
JanuviaSitagliptin Phosphate34$35,315
RybelsusSemaglutide13$30,941
ProliaDenosumab15$26,477
XareltoRivaroxaban17$25,272
Spiriva RespimatTiotropium Bromide15$19,081
MresviaRsv Vaccine, Pref, Mrna/Pf61$18,129
Repatha SureclickEvolocumab22$14,168
SymbicortBudesonide/Formoterol Fumarate25$13,849
Semglee (Yfgn) PenInsulin Glargine-Yfgn17$12,144

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$735$182,977164 claims
Novo NordiskOzempic, Rybelsus$1,116$79,62636 claims
GSKTrelegy Ellipta, Shingrix$1,112$63,41875 claims
Boehringer IngelheimJardiance, Spiriva Respimat$500$57,66250 claims
AstraZenecaFarxiga, Symbicort$895$56,86275 claims
MerckJanuvia, Janumet$234$47,14645 claims
AmgenProlia$574$26,47715 claims
Johnson & JohnsonXarelto$130$25,27217 claims
AbbVieSynthroid$1,389$2,75549 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Norton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →